Head-To-Head Review: Presbia PLC (LENS) versus Synergetics USA (NASDAQ:SURG)
Presbia PLC (NASDAQ: LENS) and Synergetics USA (NASDAQ:SURG) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, profitabiliy, earnings, institutional ownership, risk, dividends and valuation.
This is a summary of current ratings for Presbia PLC and Synergetics USA, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Presbia PLC currently has a consensus price target of $12.00, indicating a potential upside of 445.45%. Given Presbia PLC’s higher possible upside, equities analysts plainly believe Presbia PLC is more favorable than Synergetics USA.
Earnings and Valuation
This table compares Presbia PLC and Synergetics USA’s top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Presbia PLC||$16,000.00||2,331.45||-$16.18 million||N/A||N/A|
Synergetics USA has higher revenue, but lower earnings than Presbia PLC.
Insider & Institutional Ownership
19.6% of Presbia PLC shares are held by institutional investors. 74.7% of Presbia PLC shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
This table compares Presbia PLC and Synergetics USA’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Presbia PLC beats Synergetics USA on 5 of the 8 factors compared between the two stocks.
About Presbia PLC
Presbia PLC is an ophthalmic device company. The Company develops and markets an optical lens implant for treating presbyopia, the age-related loss of the ability to focus on near objects. The Company’s segment is the restoration of clear vision caused by presbyopia. The Company provides the refractive lens for patient surgeries and accessories for procedures performed exclusively outside the United States. The Company’s lens, referred to as the microlens, is a miniature lens designed to be surgically implanted in a patient’s eye to improve that patient’s ability to see objects at close distances. The microlens is a disc shaped lens that has a refractive zone in the periphery designed to improve near vision problems associated with presbyopia and a central zone that is designed to improve distance vision. The Company’s solution is a standalone solution for plano presbyopes, or those individuals suffering from presbyopia but do not have any other visual disorders.
About Synergetics USA
Synergetics USA, Inc., formerly Valley Forge Scientific Corp., is a supplier of precision surgical devices. The Company focuses on the surgical disciplines of ophthalmology and neurosurgery. It offers precision engineered disposable and reusable devices, surgical equipment and surgical procedural kits. It also delivers energy modalities for the performance of surgery, including laser energy, ultrasonic energy, radio frequency energy for electro surgery and lesion generation, visible light energy for illumination and simultaneous infusion (irrigation) of fluids into the operative field. Its products include VersaVIT 2.0 Vitrectomy System, Directional II Laser Probe and Pinnacle 360°. It offers its products under the brand names: VersaPACK, Core Essentials, Photon, Solitaire, Volk’s and Labtician’s, among others. It offers approximately 1,000 separate catalogue items in the vitreoretinal surgical market. It sells its products in approximately 60 countries outside the United States.
Receive News & Ratings for Presbia PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Presbia PLC and related companies with MarketBeat.com's FREE daily email newsletter.